Cargando…
Tissue glycomics distinguish tumour sites in women with advanced serous adenocarcinoma
In the era of precision medicine, the tailoring of cancer treatment is increasingly important as we transition from organ‐based diagnosis towards a more comprehensive and patient‐centric molecular diagnosis. This is particularly the case for high‐grade serous adenocarcinomas of the ovary and periton...
Autores principales: | Anugraham, Merrina, Jacob, Francis, Everest‐Dass, Arun V., Schoetzau, Andreas, Nixdorf, Sheri, Hacker, Neville F., Fink, Daniel, Heinzelmann‐Schwarz, Viola, Packer, Nicolle H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663998/ https://www.ncbi.nlm.nih.gov/pubmed/28853212 http://dx.doi.org/10.1002/1878-0261.12134 |
Ejemplares similares
-
Reliable in vitro studies require appropriate ovarian cancer cell lines
por: Jacob, Francis, et al.
Publicado: (2014) -
Epigenetic activation of MGAT3 and corresponding bisecting GlcNAc shortens the survival of cancer patients
por: Kohler, Reto S., et al.
Publicado: (2016) -
Careful Selection of Reference Genes Is Required for Reliable Performance of RT-qPCR in Human Normal and Cancer Cell Lines
por: Jacob, Francis, et al.
Publicado: (2013) -
Outcome in serous ovarian cancer is not associated with LATS expression
por: Montavon, Céline, et al.
Publicado: (2019) -
The Wnt Gatekeeper SFRP4 Modulates EMT, Cell Migration and Downstream Wnt Signalling in Serous Ovarian Cancer Cells
por: Ford, Caroline E., et al.
Publicado: (2013)